BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29469721)

  • 1. Lupus and scleroderma overlap features in a 28-year-old man with anti-PL-12 anti-synthetase syndrome.
    Rana J; Moy AP; Piris A; Smith GP
    Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear scleroderma occurring in a patient with systemic lupus erythematosus--short report.
    Lee CW; Kwon CW; Yoo DH; Kim SY
    J Korean Med Sci; 1994 Apr; 9(2):197-9. PubMed ID: 7986395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus erythematosus and localized scleroderma coexistent at the same sites: a rare presentation of overlap syndrome of connective-tissue diseases.
    Pascucci A; Lynch PJ; Fazel N
    Cutis; 2016 May; 97(5):359-63. PubMed ID: 27274545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent localized scleroderma and discoid lupus erythematosus. Cutaneous 'mixed' or 'overlap' syndrome.
    Umbert P; Winkelmann RK
    Arch Dermatol; 1978 Oct; 114(10):1473-8. PubMed ID: 718182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The progressive systemic sclerosis/systemic lupus overlap: an unusual clinical progression.
    Asherson RA; Angus H; Mathews JA; Meyers O; Hughes GR
    Ann Rheum Dis; 1991 May; 50(5):323-7. PubMed ID: 2042989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
    Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
    Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
    Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome.
    Alayoud A; Qamouss O; Hamzi A; Benyahia M; Oualim Z
    Arab J Nephrol Transplant; 2012 Sep; 5(3):153-7. PubMed ID: 22967254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac valvular disease in scleroderma and systemic lupus erythematosus/scleroderma overlap associated with antiphospholipid antibodies.
    Penmetcha M; Rosenbush SW; Harris CA
    J Rheumatol; 1996 Dec; 23(12):2171-4. PubMed ID: 8970061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
    J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLE/myositis overlap: are the manifestations of SLE different in overlap disease?
    Dayal NA; Isenberg DA
    Lupus; 2002; 11(5):293-8. PubMed ID: 12090563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlap syndrome with antibodies against multiple transfer-RNA components presenting antisynthetase syndrome.
    Motegi H; Kirino Y; Morishita R; Nishino I; Suzuki S
    Neuromuscul Disord; 2023 May; 33(5):405-409. PubMed ID: 37037049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus.
    Vilá LM; Molina MJ; Mayor AM; Peredo RA; Santaella ML; Vilá S
    Lupus; 2006; 15(12):892-8. PubMed ID: 17211998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of discoid lupus erythematosus to mixed connective tissue disease.
    Gilliam JN; Prystowsky SD
    J Rheumatol; 1977; 4(2):165-9. PubMed ID: 881692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study.
    Liang Y; Leng RX; Pan HF; Ye DQ
    Med Sci Monit; 2017 May; 23():2543-2549. PubMed ID: 28548078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized scleroderma and regional inflammatory myopathy.
    Zivković SA; Freiberg W; Lacomis D; Domsic RT; Medsger TA
    Neuromuscul Disord; 2014 May; 24(5):425-30. PubMed ID: 24569141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
    Rönnelid J; Barbasso Helmers S; Storfors H; Grip K; Rönnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
    Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.